Dy.Dean's Message of CREMA

Dr. R. S. Nadig
MD (Gen. Med), MD (Com. Med),
DPH DIH DAM (JBIMS)

As one of the emerging markets for outsourced Clinical Drug Development, India has established its prime place as an innovative player much sought after by various Multi national companies, CRO’s and leading sponsors for various phases of clinical research, Clinical data management and Pharmacovigilance activities.

Over the last few years, the Indian advantage of a suitable business environment, enthusiastic human resources with superior technical capabilities and the speed of completion of trials coupled with a conducive regulatory environment has made India a proud contributor and therefore has gained recognition as a lead player in ushering in Clinical Trials Industry as a sunrise Industry. Despite the threat of recession, the year 2008 has seen India emerging as a leader among the Emerging Markets with significant increase in large Phase III trials funded by the Industry.

In view of the increasing demand for global patient enrolment shifting to Asia specially India and China, the paucity of trained Clinical trial professionals, organizations such as CREMA have taken up this laudable task of creating Industry oriented curriculum delivered to carefully selected students by experienced Academicians, expert industry leaders and Management gurus.

The onus of building the right kind of capacity to meet the increasing demand for Clinical Trial professionals lies not only with organizations like CREMA but also calls for a close collaborative approach with the Industry. We at CREMA wish to place on record our deep sense of appreciation for the unstinted support, guidance and constant encouragement offered by the Pharmaceutical Industry, CRO’s and others. It gives us immense pleasure that more than 80% of our students have been recruited from campus interviews by various such organizations even before completing their course”

CREMA aims to create and nurture Clinical trial professionals who during their tenure at our various campuses learn, unlearn and relearn ultimately leading from the front in establishing India as an excellent platform for Clinical Drug Development.

Dr. R. S. Nadig
Dy.Dean
http://www.cremaindia.org/index.php?option=com_content&view=article&id=61&Itemid=57

CREMA - Impact Learning System
CREMA has five pillars of growth which are on the basis of teaching methodology, international collaboration, learning series, industry association & industry endorsed courses.


Teaching Methodology:
CREMA has designed a unique LIFSP (Learning by Industry -Faculty -Student partnership) model that establishes a close relationship between the three entities involved in the process - the student, the faculty and the industry.
LIFSP Model

At CREMA, innovation in teaching and excellence in infrastructure is a constant process. We have devised various teaching tools and methodology to impart training that goes a long way in getting our students ready for the industry. Our motive has always been to ensure our students grow into the
most sought-after professionals.

International Collaboration:
The institute believes in making its courses globally credible through tie-ups with world class institutions. A beginning has been made here with its affiliation with UK-based William Harvey Research Ltd. CREMA has also collaborated with Canada’s Clinical Research International for online programmes.
Learning Series:
The focus here will be on reaching out to the issues of the industry and student community through conferences and training programmes. CREMA has partnered with US-based D. Anderson & Company for organizing conferences on issues affecting the clinical research industry like on patient recruitment & retention. Its Corporate Training Programme (CTP) is focused on revising & upgrading the knowledge of CR professionals in the industry through class room sessions and workshops.
Industry Association:
CREMA believes that various stake holders of the clinical research industry should unite to put across their voices together for the betterment of the industry. CREMA is the only player among training institutes, which is part of Indian Society of Clinical Research (ISCR), an association of leading firms connected with clinical research.
Industry Endorsed Courses:
CREMA has constituted its curriculum after deep consultation with the industry. It believes that curriculum needs to be renewed and upgraded on the basis of industrial priority.
http://www.cremaindia.org/index.php?option=com_content&view=article&id=52&Itemid=45
Faculty team at CREMA
Renowned and experienced names from the Clinical Research industry have come together to form the faculty team at CREMA. These expert minds implement a dynamic mix of lectures, case studies and hands-on learning through tried & tested tools and methods. They not only assist students in developing active interest in the curriculum but also in planning a successful career in Clinical Research.
• Permanent Faculty
• Visiting Faculty
http://www.cremaindia.org/index.php?option=com_content&view=article&id=30&Itemid=29